{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:01Z","timestamp":1791409861650,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.exger.2026.113155","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:05:52Z","timestamp":1777964752000},"page":"113155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum and plasma glial fibrillary acidic protein in patients with schizophrenia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"220","author":[{"given":"Rasoul","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehra","family":"Fekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakiba","family":"Salarvandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Tahmasbi Arashlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokoofe","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med. Res. Methodol."},{"issue":"24","key":"10.1016\/j.exger.2026.113155_bb0010","doi-asserted-by":"crossref","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte biomarkers in Alzheimer Disease: a systematic review and meta-analysis","volume":"96","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.exger.2026.113155_bb0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1586\/ern.09.59","article-title":"Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy","volume":"9","author":"Bernstein","year":"2009","journal-title":"Expert Rev. Neurother."},{"issue":"4","key":"10.1016\/j.exger.2026.113155_bb0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/00048674241312805","article-title":"Blood biomarker profiles in young-onset neurocognitive disorders: a cohort study","volume":"59","author":"Bhalala","year":"2025","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.exger.2026.113155_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00060","article-title":"Rethinking schizophrenia in the context of normal neurodevelopment","volume":"7","author":"Catts","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.exger.2026.113155_bb0035","first-page":"155","article-title":"Decreased serum levels of glial markers and their relation with clinical parameters in patients with schizophrenia","volume":"26","author":"\u00c7etin","year":"2023","journal-title":"Derg. Klin. Psikiyatri"},{"key":"10.1016\/j.exger.2026.113155_bb0040","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"key":"10.1016\/j.exger.2026.113155_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euroneuro.2025.07.004","article-title":"Blood-based biomarkers of neuroaxonal and astroglial injury identify ultra-treatment-resistant schizophrenia","volume":"99","author":"de Oliveira","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.exger.2026.113155_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2013.05.016","article-title":"The evidence for illness progression after relapse in schizophrenia","volume":"148","author":"Emsley","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.exger.2026.113155_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123291","article-title":"Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders","volume":"467","author":"Eratne","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.exger.2026.113155_bb0060","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.exger.2026.113155_bb0065","doi-asserted-by":"crossref","first-page":"S505","DOI":"10.1016\/S0924-977X(09)70799-0","article-title":"Glial fibrillary acidic protein (GFAP) and S100B protein serum levels in recent onset schizophrenia","volume":"19","author":"Fekkes","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.exger.2026.113155_bb0070","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/embj.201387637","article-title":"Epigenetic memory: the Lamarckian brain","volume":"33","author":"Fischer","year":"2014","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biopsych.2005.02.008","article-title":"Cerebral cortical gray expansion associated with two second-generation antipsychotics","volume":"58","author":"Garver","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","article-title":"Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells","volume":"36","author":"Gass\u00f3","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Pt 4","key":"10.1016\/j.exger.2026.113155_bb0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","article-title":"The neuropathology of schizophrenia. A critical review of the data and their interpretation","volume":"122","author":"Harrison","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.exger.2026.113155_bb0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2022.05.004","article-title":"Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia","volume":"151","author":"Huang","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.exger.2026.113155_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2022.05.004","article-title":"Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia","volume":"151","author":"Huang","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"7321","key":"10.1016\/j.exger.2026.113155_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.exger.2026.113155_bb0105","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.exger.2026.113155_bb0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuron.2015.05.046","article-title":"Building the neuronal microtubule cytoskeleton","volume":"87","author":"Kapitein","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41398-017-0071-9","article-title":"Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience","volume":"8","author":"Kesby","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.exger.2026.113155_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pnpbp.2017.10.002","article-title":"Astroglial correlates of neuropsychiatric disease: from astrocytopathy to astrogliosis","volume":"87","author":"Kim","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.exger.2026.113155_bb0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/schbul\/sbu070","article-title":"Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage","volume":"40","author":"Kochunov","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.exger.2026.113155_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pscychresns.2017.03.005","article-title":"Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia","volume":"263","author":"Larivi\u00e8re","year":"2017","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"2016\u2013January","key":"10.1016\/j.exger.2026.113155_bb0135","first-page":"466","article-title":"The glio-fibrillar acid protein in blood serum of patients with brain tumors and neurological diseases of non-tumorous etiology","volume":"8","author":"Lyubimova","year":"2016","journal-title":"Klin. Lab. Diagn."},{"issue":"2","key":"10.1016\/j.exger.2026.113155_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tips.2007.11.005","article-title":"Functional neuroimaging in schizophrenia: diagnosis and drug discovery","volume":"29","author":"McGuire","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0145","first-page":"1","article-title":"The jackknife-a review","volume":"61","author":"Miller","year":"1974","journal-title":"Biometrika"},{"issue":"1\u20133","key":"10.1016\/j.exger.2026.113155_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.schres.2011.12.010","article-title":"Regional differences in expression of \u03b2-tubulin isoforms in schizophrenia","volume":"135","author":"Moehle","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.exger.2026.113155_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpsychires.2024.10.007","article-title":"Longitudinal analysis of astrocyte-derived protein levels in the blood of drug-naive and relapsed patients with schizophrenia","volume":"180","author":"Mukherjee","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.exger.2026.113155_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpsychires.2024.10.007","article-title":"Longitudinal analysis of astrocyte-derived protein levels in the blood of drug-naive and relapsed patients with schizophrenia","volume":"180","author":"Mukherjee","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"issue":"2\u20133","key":"10.1016\/j.exger.2026.113155_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0920-9964(02)00339-0","article-title":"Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia","volume":"57","author":"Rajkowska","year":"2002","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000369214","article-title":"Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls","volume":"15","author":"Rao","year":"2015","journal-title":"Neurodegener Dis"},{"issue":"12","key":"10.1016\/j.exger.2026.113155_bb0180","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","article-title":"Neurodevelopmental model of schizophrenia: update 2012","volume":"17","author":"Rapoport","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.exger.2026.113155_bb0185","author":"Rayyan"},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71060-4","article-title":"Plasma \u03b2-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia","volume":"10","author":"Rodrigues-Amorim","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.exger.2026.113155_bb0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/08039480902767286","article-title":"Is schizophrenia a neurodegenerative disorder?","volume":"63","author":"Rund","year":"2009","journal-title":"Nord. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.exger.2026.113155_bb0205","article-title":"The role of glial fibrillary acidic protein as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder: a systematic review and meta-analysis","volume":"60","author":"Shaygannejad","year":"2024","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.exger.2026.113155_bb0210","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/npjschz.2016.3","article-title":"Early interventions in risk groups for schizophrenia: what are we waiting for?","volume":"2","author":"Sommer","year":"2016","journal-title":"NPJ Schizophr."},{"issue":"1\u20133","key":"10.1016\/j.exger.2026.113155_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.schres.2008.04.032","article-title":"Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia","volume":"103","author":"Steffek","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.exger.2026.113155_bb0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpsychires.2021.09.012","article-title":"Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder","volume":"144","author":"Steinacker","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.exger.2026.113155_bb0225","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/jnnp.2006.093427","article-title":"Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones","volume":"77","author":"Steiner","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acn3.51708","article-title":"Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis","volume":"10","author":"Verde","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.exger.2026.113155_bb0235","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11064-014-1403-2","article-title":"Why are astrocytes important?","volume":"40","author":"Verkhratsky","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.exger.2026.113155_bb0240","author":"WebPlotDigitizer"},{"issue":"2","key":"10.1016\/j.exger.2026.113155_bb0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuroscience.2005.02.037","article-title":"Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia","volume":"133","author":"Webster","year":"2005","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.exger.2026.113155_bb0250","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.exger.2026.113155_bb0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00406-012-0328-5","article-title":"Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia","volume":"263","author":"Williams","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.exger.2026.113155_bb0260","doi-asserted-by":"crossref","first-page":"E794","DOI":"10.4088\/JCP.13m08772","article-title":"Combining serum protein concentrations to diagnose schizophrenia: A preliminary exploration","volume":"75","author":"Xiong","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.exger.2026.113155_bb0265","series-title":"Effect of Systemic Family Therapy on Rehabilitation in Patients With Schizophrenia","year":"2016"}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556526001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556526001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:25:56Z","timestamp":1780043156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556526001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"alternative-id":["S0531556526001348"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2026.113155","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and plasma glial fibrillary acidic protein in patients with schizophrenia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2026.113155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113155"}}